IL-6, MMP 3 and prognosis in previously healthy sepsis patients
<p>Sepsis and septic shock are clinical conditions with high mortality despite advances in technology and are the leading cause of death in intensive care. Clinical manifestations and morbidity may be attributable to a disproportionate increase in proinflammatory cytokines. The aim of this stu...
Main Authors: | Juan Pablo Ricarte-Bratti, Nicolas Jaime-Albarrán, Hilda Lucrecia Montrull, Nilda Yolanda Brizuela |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidad Nacional de Córdoba
2017-06-01
|
Series: | Revista de la Facultad de Ciencias Médicas de Córdoba |
Subjects: | |
Online Access: | https://revistas.unc.edu.ar/index.php/med/article/view/14608 |
Similar Items
-
Inflammatory Mediator Profiles Differ in Sepsis Patients With and Without Bacteremia
by: Knut Anders Mosevoll, et al.
Published: (2018-04-01) -
The roles of interleukin-17A in risk stratification and prognosis of patients with sepsis-associated acute kidney injury
by: Heng Jin, et al.
Published: (2023-11-01) -
Coagulation factor protein abundance in the pre-septic state predicts coagulopathic activities that arise during late-stage murine sepsis
by: Douglas M. Heithoff, et al.
Published: (2022-04-01) -
Induction of Matrix Metalloproteinases in Chondrocytes by Interleukin IL-1β as an Osteoarthritis Model
by: Ervi Afifah, et al.
Published: (2019-08-01) -
Biology of Interleukin-17 and Its Pathophysiological Significance in Sepsis
by: Yun Ge, et al.
Published: (2020-07-01)